Preventing Opportunistic Infections in Human Immunodeficiency Virus-Infected Persons: Implications for the Developing World

Jonathan E. Kaplan Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases and the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Center for AIDS and STD, University of Washington, Critical Care Medicine Department, National Institutes of Health, London School of Hygiene and Tropical Medicine, Atlanta, Georgia

Search for other papers by Jonathan E. Kaplan in
Current site
Google Scholar
PubMed Close
,
Dale J. Hu Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases and the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Center for AIDS and STD, University of Washington, Critical Care Medicine Department, National Institutes of Health, London School of Hygiene and Tropical Medicine, Atlanta, Georgia

Search for other papers by Dale J. Hu in
Current site
Google Scholar
PubMed Close
,
King K. Holmes Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases and the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Center for AIDS and STD, University of Washington, Critical Care Medicine Department, National Institutes of Health, London School of Hygiene and Tropical Medicine, Atlanta, Georgia

Search for other papers by King K. Holmes in
Current site
Google Scholar
PubMed Close
,
Harold W. Jaffe Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases and the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Center for AIDS and STD, University of Washington, Critical Care Medicine Department, National Institutes of Health, London School of Hygiene and Tropical Medicine, Atlanta, Georgia

Search for other papers by Harold W. Jaffe in
Current site
Google Scholar
PubMed Close
,
Henry Masur Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases and the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Center for AIDS and STD, University of Washington, Critical Care Medicine Department, National Institutes of Health, London School of Hygiene and Tropical Medicine, Atlanta, Georgia

Search for other papers by Henry Masur in
Current site
Google Scholar
PubMed Close
, and
Kevin M. De Cock Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases and the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Center for AIDS and STD, University of Washington, Critical Care Medicine Department, National Institutes of Health, London School of Hygiene and Tropical Medicine, Atlanta, Georgia

Search for other papers by Kevin M. De Cock in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1996.55.1.TM0550010001
Volume/Issue:
Volume 55: Issue 1
Page(s):
1–11
Restricted access
Get Permissions

More than 18 million persons in the world are estimated to have been infected with human immunodeficiency virus (HIV), the cause of the acquired immunodeficiency syndrome (AIDS). As immunodeficiency progresses, these persons become susceptible to a wide variety of opportunistic infections (OIs) The spectrum of OIs varies among regions of the world. Tuberculosis is the most common serious OI in sub-Saharan Africa and is also more common in Latin America and in Asia than in the United States. Bacterial and parasitic infections are prevalent in Africa; protozoal infections such as toxoplasmosis, cryptosporidiosis, and isosporiasis are also common in Latin America. Fungal infections, including cryptococcosis and Penicillium marneffei infection, appear to be prevalent in Southeast Asia. Despite limited health resources in these regions, some measures that are recommended to prevent OIs in the United States may be useful for prolonging and improving the quality of life of HIV-infected persons. These include trimethoprim-sulfamethoxazole to prevent Penumocystis carinii pneumonia, toxoplasmosis, and bacterial infections; isoniazid to prevent tuberculosis; and 23-valent pneumococcal vaccine to prevent disease due to Streptococcus pneumoniae. Research is needed to determine the spectrum of OIs and the efficacy of various prevention measures in resource-poor nations, and health officials need to determine a minimum standard of care for HIV-infected persons. An increasing problem in the developing world, HIV/AIDS should receive attention comparable to other tropical diseases.
Copyright:
Copyright © 1996 by The American Society of Tropical Medicine and Hygiene 1996
Published Online:
Jul 1996
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 425 173 7
Full Text Views 12 0 0
PDF Downloads 12 0 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save